BSACI position statement: Cost of living, health inequalities and the adverse additional impact on children and young people living with allergic conditions VIEW HERE
BSACI statement: NICE approval of Palforzia, a treatment for peanut allergy in children and young people VIEW HERE
23 Sep 2024 Announcements, Latest news, FGS Ingredients Ltd recalls several products containing mustard powder because of...
